Related Experiment Video
Updated: Aug 22, 2026

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
Published on: December 4, 2016
Polyamine dendrimer-based MRI contrast agents for functional kidney imaging to diagnose acute renal failure
Hisataka Kobayashi1, Sang-Kyung Jo, Satomi Kawamoto
1Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Kobayash@mail.nih.gov
Purpose:
To choose an efficacious renal functional MRI contrast agent to image early renal tubular damage. We synthesized and compared smaller polyamine dendrimer-based MRI contrast agents (<60 kD) that, unlike Gd-[DTPA], transiently accumulate in renal tubules and can be used to visualize renal structural and functional damage.
Materials And Methods:
Six dendrimer-based MRI contrast agents smaller than 60 kD were studied by high resolution dynamic micro-MRI and compared to Gd-[DTPA]-dimeglumine and Gadomer-17. The best agent, DAB-G2, was further tested in a mouse ischemia/reperfusion model to validate its efficacy.
Results:
Despite unequal renal clearance rates, all polyamine dendrimer agents visualized the renal functional anatomy of the mice better than Gd-[DTPA]-dimeglumine and Gadomer-17. DAB-G2 was excreted most rapidly, yet was able to visualize mild renal tubular injury very early after injury.
Conclusion:
DAB-G2 was found to be the best candidate for functional kidney imaging and enabled early diagnosis of acute renal injury.
Insights
Researchers developed novel polyamine dendrimer MRI contrast agents for early detection of kidney damage. The agent DAB-G2 effectively visualizes renal tubular injury, aiding in early diagnosis of acute kidney injury.
Area of Science:
- Biomedical imaging
- Nanotechnology
- Renal medicine
Background:
- Current MRI contrast agents like Gd-DTPA have limitations in visualizing early renal tubular damage.
- Developing novel contrast agents is crucial for early and accurate diagnosis of kidney injuries.
- Dendrimer-based nanoparticles offer unique properties for targeted imaging applications.
Purpose of the Study:
- To identify an effective renal functional MRI contrast agent for imaging early renal tubular damage.
- To synthesize and compare small polyamine dendrimer-based MRI contrast agents (<60 kD).
- To evaluate agents for transient accumulation in renal tubules for visualizing structural and functional damage.
Main Methods:
- Six dendrimer-based MRI contrast agents (<60 kD) were synthesized and evaluated.
- High-resolution dynamic micro-MRI was used for agent comparison.
- The lead agent, DAB-G2, was tested in a mouse ischemia/reperfusion model.
Main Results:
- All polyamine dendrimer agents demonstrated superior visualization of renal functional anatomy compared to Gd-DTPA-dimeglumine and Gadomer-17.
- DAB-G2 exhibited rapid excretion while effectively visualizing early, mild renal tubular injury.
- The agents showed varying but effective renal clearance rates.
Conclusions:
- DAB-G2 is a promising candidate for functional kidney imaging.
- This agent enables early diagnosis of acute renal injury.
- Polyamine dendrimer agents represent an advancement in renal MRI contrast agents.
More Related Videos
Related Concept Videos
Imaging Studies IV: Magnetic Resonance Imaging
Imaging Studies VII: Vascular Imaging
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Imaging Studies V: Intravenous Urography and Retrograde Pyelography
Acute Kidney Injury I: Introduction
Magnetic Resonance Imaging

